Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States

Journal of Clinical Psychiatry

Volumn 77, Issue 6, 2016, Pages 772-780

  Saha, Tulshi D ^a   Kerridge, Bradley T ^b   Goldstein, Rise B ^a   Chou, S Patricia ^a   Zhang, Haitao ^a   Jung, Jeesun ^a   Pickering, Roger P ^a   Ruan, W June ^a   Smith, Sharon M ^a   Huang, Boji ^a   Hasin, Deborah S ^c   Grant, Bridget F ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b Columbia University ^*  (United States)

^c New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ADULT; AGED; ANTISOCIAL PERSONALITY DISORDER; ARTICLE; BIPOLAR I DISORDER; BORDERLINE STATE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; DSM-5; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NONMEDICAL PRESCRIPTION OPIOID USE; NONMEDICAL PRESCRIPTION OPIOID USE DISORDER; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOTYPAL PERSONALITY DISORDER; SEX DIFFERENCE; SOCIAL STATUS; SUBSTANCE ABUSE; UNITED STATES; ADOLESCENT; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG MISUSE; HEALTH SURVEY; MENTAL DISORDERS; MIDDLE AGED; OPIOID-RELATED DISORDERS; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; STATISTICS AS TOPIC; UNITED STATES; YOUNG ADULT;

EID: 84976381980     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m10386     Document Type: Article

References (104)

1. Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education. Relieving Pain in American: A Blueprint for Transforming Prevention, Care, Education and Research. Washington, DC: The National Academies Press; 2011.
2. Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241-248. doi:10.1056/NEJMsa1406143
3. National Institute on Drug Abuse. America's Addiction to Opioids: Heroin and Prescription Drug Abuse. Rockville, MD: National Institute on Drug Abuse; 2015.
4. Warner M, Hedegaard H. Chen L-H. Trends in Drug-poisoning Deaths Involving Opioid Analgesics and Heroin: United States. Atlanta, GA: Centers for Disease Control; 2012.
5. Substance Abuse and Mental Health Administration and Center for Behavioral Health Statistics and Quality. Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visit. Rockville, MD: Substance Abuse and Mental Health Administration and Center for Behavioral Health Statistics and Quality; 2013.
6. Substance Abuse and Mental Health Administration. Treatment Episode Data Set (TEDS) 2002-2012. Rockville, MD: Substance Abuse and Mental Health Administration; 2014.
7. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1-2):95-100. doi:10.1016/j.drugalcdep.2013.01.07
8. Pollini RA, Banta-Green CJ, Cuevas-Mota J, et al. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil. 2011;2(1):173-180. doi:10.2147/SAR.S2480
9. Muhuri PK, Gfroerer JC, Davis MC. Associations on Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States. Rockville, MD: Substance Abuse and Mental Health Administration and Center for Behavioral Health Statistics and Quality; 2013.
10. Miller M, St'mer T, Azrael D, et al. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59(3):430-438. doi:10.1/j.1532-5415.201.0318.x
11. Rolita L, Spegman A, Tang X, et al. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013;61(3):335-340. doi:10.1/jgs.12148
12. Creanga AA, Sabel JC, Ko JY, et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol. 2012;119(5):924-933. doi:10.1097/AOG.0b013e31824ea276
13. US Department of Health and Human Services. Addressing Prescription Drug Abuse in the United States: Current Activities and Future Opportunities. Washington, DC: US Department of Health and Human Services; 2011.
14. Birnbaum HG, White AG, Schiller M, et al. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657-667. doi:10.1/j.1526-4637.201.01075.x
15. Coalition Against Insurance Fraud. Prescription for Peril: How Insurance Fraud Finances Theft and Abuse of Addictive Prescription Drugs. Washington, DC: Coalition Against Insurance Fraud; 2007.
16. Hansen RN, Oster G, Edelsberg J, et al. Economic costs of nonmedical use of prescription opioids. Clin J Pain. 2011;27(3):194-202. doi:10.1097/AJP.0b013e3181f04ca
17. Amari E, Rehm J, Goldner E, et al. Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry. 2011;56(8):495-502.
18. Beauchamp GA, Winstanley EL, Ryan SA, et al. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health. 2014;104(11):2023-2029. doi:10.2105/AJPH.2014.302147
19. McHugh RK, Nielsen S, Weiss RD. Prescription drug abuse: from epidemiology to public policy. J Subst Abuse Treat. 2015;48(1):1-7. doi:10.1016/j.jsat.2014.08.04
20. Parsells Kelly J, Cook SF, Kaufman DW, et al. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138(3):507-513. doi:10.1016/j.pain.208.01.027
21. Tetrault JM, Desai RA, Becker WC, et al. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction. 2008;103(2):258-268. doi:10.1/j.1360-043.207.02056.x
22. Huang B, Dawson DA, Stinson FS, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67(7):1062-1073.
23. Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health - Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
24. Grant BF, Kaplan K, Shepard J, et al. Source and Accuracy Statement of Wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2001.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
26. Becker WC, Sullivan LE, Tetrault JM, et al. Nonmedical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94(1-3):38-47. doi:10.1016/j.drugalcdep.207.09.018
27. Compton WM, Conway KP, Stinson FS, et al. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(6):677-685. doi:10.408/JCP.v6n0602
28. Katz C, El-Gabalawy R, Keyes KM, et al. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample. Drug Alcohol Depend. 2013;132(1-2):107-113. doi:10.1016/j.drugalcdep.2013.01.010
29. Martins SS, Fenton MC, Keyes KM, et al. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42(6):1261-1272. doi:10.1017/S032917102145
30. Martins SS, Keyes KM, Storr CL, et al. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009;103(1-2):16-24. doi:10.1016/j.drugalcdep.209.01.019
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington, DC: American Psychiatric Association; 2013.
32. Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834-851. doi:10.176/api.ajp.2013.12060782
33. Grant BF, Amsbary M, Chu A, et al. Sources and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2014.
34. Centers for Disease Control and Prevention. Unweighted Response Rates for the NHANES 2011-2012. Atlanta, GA: Centers for Disease Control and Prevention; 2013.
35. Bureau of the Census. American Community Survey, 2012. Suitland, MD: Bureau of the Census; 2013.
36. Grant BF, Goldstein RB, Chou SP, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-Diagnostic and Statistical Manual of Mental Disorders Fifth Edition Version (AUDADIS-5). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2011.
37. Grant BF, Harford TC, Dawson DA, et al. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37-44. doi:10.1016/0376-8716(95)0134-K
38. Grant BF, Goldstein RB, Smith SM, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug Alcohol Depend. 2015;148(1):27-33. doi:10.1016/j.drugalcdep.2014.1.026
39. Hasin DS, Aivadyan C, Greenstein E, et al. Psychiatric Research Interview for Substance Use and Mental Disorders, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PRISM-5) Version. New York, NY: Columbia University, Department of Psychiatry; 2011.
40. Hasin DS, Greenstein E, Aivadyan C, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend. 2015;148:40-46. doi:10.1016/j.drugalcdep.2014.12.01
41. Chatterji S, Saunders JB, Vrasti R, et al. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule-Alcohol/ Drug-Revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997;47(3):171-185. doi:10.1016/S0376-8716(97)08-4
42. Hasin D, Carpenter KM, McCloud S, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44(2-3):133-141. doi:10.1016/S0376-8716(97)0132-X
43. Canino G, Bravo M, Ramez R, et al. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60(6):790-799. doi:10.1528/jsa.19.60.790
44. Hasin DS, Muthuen B, Wisnicki KS, et al. Validity of the bi-axial dependence concept: a test in the US general population. Addiction. 1994;89(5):573-579. doi:10.1/j.1360-043.194.tb03.x
45. Nelson CB, Rehm J, Ust TB, et al. Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction. 1999;94(6):843-855. doi:10.1046/j.1360-043.19.9468438.x
46. Saha TD, Compton WM, Chou SP, et al. Analyses related to the development of DSM-5 criteria for substance use related disorders, 1: toward amphetamine, cocaine and prescription drug use disorder continua using Item Response Theory. Drug Alcohol Depend. 2012;122(1-2):38-46. doi:10.1016/j.drugalcdep.201.09.04
47. Cottler LB, Grant BF, Blaine J, et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47(3):195-205. doi:10.1016/S0376-8716(97)090-2
48. Hasin DS, Shmulewitz D, Stohl M, et al. Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: substance abusers and others in the general population. Drug Alcohol Depend. 2015;152:246-256. doi:10.1016/j.drugalcdep.2015.03.027
49. Research Triangle Institute. SUDAAN Language Manual, Release 11.0. Research Triangle Park, NC: The Institute; 2012.
50. Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician. 2014;17(2):E119-E128.
51. Fleary SA, Heffer RW, McKyer EL. Understanding nonprescription and prescription drug misuse in late adolescence/ young adulthood. J Addict. 2013;2013:709207. doi:10.15/2013/709207
52. Manchikanti L, Fellows B, Ailinani H, et al. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13(5):401-435.
53. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11(suppl):S63-S88.
54. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(suppl):ES67-ES92.
55. Back SE, Payne RL, Simpson AN, et al. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav. 2010;35(11):1001-1007. doi:10.1016/j.adbeh.2010.06.018
56. Roe CM, McNamara AM, Motheral BR. Genderand age-related prescription drug use patterns. Ann Pharmacother. 2002;36(1):30-39. doi:10.1345/aph.1A13
57. Simoni-Wastila L. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med. 2000;9(3):289-297. doi:10.1089/15246090318470
58. Cicero TJ, Lynskey M, Todorov A, et al. Comorbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain. 2008;139(1):127-135. doi:10.1016/j.pain.208.03.021
59. Back SE, Lawson KM, Singleton LM, et al. Characteristics and correlates of men and women with prescription opioid dependence. Addict Behav. 2011;36(8):829-834. doi:10.1016/j.adbeh.201.03.013
60. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(5):566-576. doi:10.101/archpsyc.64.5.56
61. Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(11):1107-1115. doi:10.101/archpsyc.61.1.107
62. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830-842. doi:10.101/archpsyc.64.7.830
63. Stinson FS, Grant BF, Dawson DA, et al. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005;80(1):105-116. doi:10.1016/j.drugalcdep.205.03.09
64. Stinson FS, Ruan WJ, Pickering R, et al. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med. 2006;36(10):1447-1460. doi:10.1017/S0329170608361
65. Garcia-Cebrian A, Gandhi P, Demyttenaere K, et al. The association of depression and painful physical symptoms-a review of the European literature. Eur Psychiatry. 2006;21(6):379-388. doi:10.1016/j.eurpsy.205.12.03
66. Rijavec N, Grubic VN. Depression and pain: often together but still a clinical challenge: a review. Psychiatr Danub. 2012;24(4):346-352.
67. Brown RL, Patterson JJ, Rounds LA, et al. Substance abuse among patients with chronic back pain. J Fam Pract. 1996;43(2):152-160.
68. Chelminski PR, Ives TJ, Felix KM, et al. A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res. 2005;5(1):3. doi:10.186/1472-6963-5-3
69. Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors' a structured evidence-based review. Pain Med. 2008;9(4):444-459. doi:10.1/j.1526-4637.207.0370.x
70. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116-127. doi:10.7326/03-4819-146-2-2070160-06
71. Minozzi S, Amato L, Davoli M. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction. 2013;108(4):688-698. doi:10.1/j.1360-043.2012.0405.x
72. Sullivan MD, Howe CQ. Opioid therapy for chronic pain in the United States: promises and perils. Pain. 2013;154(suppl 1):S94-S100. doi:10.1016/j.pain.2013.09.09
73. Thomas E, Peat G, Harris L, et al. The prevalence of pain and pain interference in a general population of older adults: cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain. 2004;110(1-2):361-368. doi:10.1016/j.pain.204.04.017
74. West NA, Severtson SG, Green JL, et al. Trends in abuse and misuse of prescription opioids among older adults. Drug Alcohol Depend. 2015;149:117-121. doi:10.1016/j.drugalcdep.2015.01.027
75. Wu L-T, Blazer DG. Illicit and nonmedical drug use among older adults: a review. J Aging Health. 2011;23(3):481-504. doi:10.17/089826431038624
76. Martins SS, Keyes KM, Storr CL, et al. Birthcohort trends in lifetime and past-year prescription opioid-use disorder resulting from nonmedical use: results from two national surveys. J Stud Alcohol Drugs. 2010;71(4):480-487. doi:10.1528/jsad.2010.71.480
77. National Institute on Aging. US Department of Commerce, Economics and Statistics Administration, United States Census Bureau. Aging in the United States-Past, Present, and Future. Washington, DC: US Department of Commerce; 2012.
78. Simoni-Wastila L, Yang HK. Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother. 2006;4(4):380-394. doi:10.1016/j.amjopharm.206.10.02
79. Martins SS, Kim JH, Chen L-Y, et al. Nonmedical prescription drug use among US young adults by educational attainment. Soc Psychiatry Psychiatr Epidemiol. 2015;50(5):713-724. doi:10.107/s0127-014-0980-3
80. Wang KH, Becker WC, Fiellin DA. Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents. Drug Alcohol Depend. 2013;127(1-3):156-162. doi:10.1016/j.drugalcdep.2012.06.027
81. Wu L-T, Blazer DG, Swartz MS, et al; NIDA AAPI Workgroup. Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/ Pacific Islanders, and mixed-race individuals. Drug Alcohol Depend. 2013;133(2):360-367. doi:10.1016/j.drugalcdep.2013.06.08
82. Kuehn BM. CDC: major disparities in opioid prescribing among states: some states crack down on excess prescribing. JAMA. 2014;312(7):684-686. doi:10.101/jama.2014.9253
83. Fischer B, Lusted A, Roerecke M, et al. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. J Pain. 2012;13(11):1029-1044. doi:10.1016/j.jpain.2012.07.013
84. Boyd CJ, Teter CJ, West BT, et al. Non-medical use of prescription analgesics: a three-year national longitudinal study. J Addict Dis. 2009;28(3):232-242. doi:10.1080/105080903028452
85. Frankenburg FR, Fitzmaurice GM, Zanarini MC. The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. J Clin Psychiatry. 2014;75(4):357-361. doi:10.408/JCP.13m0857
86. Tragesser SL, Jones RE, Robinson RJ, et al. Borderline personality disorder features and risk for prescription opioid use disorders. J Pers Disord. 2013;27(4):427-441. doi:10.1521/pedi201327094
87. Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31(6):564-570. doi:10.1016/j.genhospsych.209.07.03
88. Edlund MJ, Martin BC, Devries A, et al. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26(1):1-8. doi:10.1097/AJP.0b013e3181b9f35
89. Eriksen J, Sjren P, Bruera E, et al. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125(1-2):172-179. doi:10.1016/j.pain.206.06.09
90. France RD. Psychiatric aspects of pain. Clin J Pain. 1989;5(suppl 2):S35-S41, discussion S41-S42. doi:10.1097/02508-19890602-06
91. Gureje O, Von Korff M, Kola L, et al. The relation between multiple pains and mental disorders: results from the World Mental Health Surveys. Pain. 2008;135(1-2):82-91. doi:10.1016/j.pain.207.05.05
92. Kobus AM, Smith DH, Morasco BJ, et al. Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain. 2012;13(11):1131-1138. doi:10.1016/j.jpain.2012.09.03
93. Morasco BJ, Duckart JP, Carr TP, et al. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic noncancer pain. Pain. 2010;151(3):625-632. doi:10.1016/j.pain.2010.08.02
94. Novak SP, Herman-Stahl M, Flannery B, et al. Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug Alcohol Depend. 2009;100(1-2):63-70. doi:10.1016/j.drugalcdep.208.09.013
95. Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940-947. doi:10.101/jama.2012.234
96. Weisner CM, Campbell CI, Ray GT, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009;145(3):287-293. doi:10.1016/j.pain.209.05.06
97. Blanco C, Iza M, Schwartz RP, et al. Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. Drug Alcohol Depend. 2013;131(1-2):143-148. doi:10.1016/j.drugalcdep.2012.12.013
98. Blanco C, Alderson D, Ogburn E, et al. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007;90(2-3):252-260. doi:10.1016/j.drugalcdep.207.04.05
99. Zacny J, Bigelow G, Compton P, et al. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69(3):215-232. doi:10.1016/S0376-8716(03)03-6.PubMed
100. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health Public Use Files, 2002-2013. Ann Arbor, MI: Inter-University Consortium for Political and Social Research; 2002-2013.
101. Grucza RA, Abbacchi AM, Przybeck TR, et al. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction. 2007;102(4):623-629. doi:10.1/j.1360-043.207.01745.x PubMed.
102. Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015;23(2):63-75. doi:10.1097/HRP.075 PubMed.
103. Fullerton CA, Kim M, Thomas CP, et al. Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv. 2014;65(2):146-157. doi:10.176/api.ps.20130235.PubMed.
104. Thomas CP, Fullerton CA, Kim M, et al. Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv. 2014;65(2):158-170.